|
1
|
Schuler Iv CF and Montejo JM: Allergic
rhinitis in children and adolescents. Pediatr Clin North Am.
66:981–993. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Schuler Iv CF and Montejo JM: Allergic
rhinitis in children and adolescents. Immunol Allergy Clin North
Am. 41:613–625. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hoyte FCL and Nelson HS: Recent advances
in allergic rhinitis. F1000Res. 7(1333)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Siddiqui ZA, Walker A, Pirwani MM, Tahiri
M and Syed I: Allergic rhinitis: Diagnosis and management. Br J
Hosp Med (Lond). 83:1–9. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Incorvaia C, Cavaliere C, Frati F and
Masieri S: Allergic rhinitis. J Biol Regul Homeost Agents. 32 (1
Suppl 1):S61–S66. 2018.PubMed/NCBI
|
|
6
|
Meng Y, Wang C and Zhang L: Advances and
novel developments in allergic rhinitis. Allergy. 75:3069–3076.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ghezzi M, Pozzi E, Abbattista L, Lonoce L,
Zuccotti GV and D'Auria E: Barrier impairment and Type 2
inflammation in allergic diseases: The pediatric perspective.
Children (Basel). 8(1165)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu S, Yu B, Dai J and Chen R: Targeting
the biological activity and biosynthesis of hyperforin: A
mini-review. Chin J Nat Med. 20:721–728. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li XX, Yan Y, Zhang J, Ding K, Xia CY, Pan
XG, Shi YJ, Xu JK, He J and Zhang WK: Hyperforin: A natural lead
compound with multiple pharmacological activities. Phytochemistry.
206(113526)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wu S, Malaco Morotti AL, Wang S, Wang Y,
Xu X, Chen J, Wang G and Tatsis EC: Convergent gene clusters
underpin hyperforin biosynthesis in St John's wort. New Phytol.
235:646–661. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Novelli M, Masiello P, Beffy P and
Menegazzi M: Protective role of St. John's wort and its components
hyperforin and hypericin against diabetes through inhibition of
inflammatory signaling: Evidence from in vitro and in vivo studies.
Int J Mol Sci. 21(8108)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nawrot J, Gornowicz-Porowska J,
Budzianowski J, Nowak G, Schroeder G and Kurczewska J: Medicinal
herbs in the relief of neurological, cardiovascular, and
respiratory symptoms after COVID-19 infection a literature review.
Cells. 11(1897)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang S, Zhang J, Yu J, Chen X, Zhang F,
Wei W, Zhang L, Chen W, Lin N and Wu Y: Hyperforin ameliorates
imiquimod-induced psoriasis-like murine skin inflammation by
modulating IL-17A-producing γδ T cells. Front Immunol.
12(635076)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lemmen J, Tozakidis IE and Galla HJ:
Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at
the blood-brain barrier. Brain Res. 1491:1–13. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang B, Gao Y, Zheng G, Ren X, Sun B, Zhu
K, Luo H, Wang Z and Xu M: Platycodin D inhibits
interleukin-13-induced the expression of inflammatory cytokines and
mucus in nasal epithelial cells. Biomed Pharmacother. 84:1108–1112.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kakli HA and Riley TD: Allergic rhinitis.
Prim Care. 43:465–475. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Campo P, Eguiluz-Gracia I, Bogas G, Salas
M, Plaza Serón C, Pérez N, Mayorga C, Torres MJ, Shamji MH and
Rondon C: Local allergic rhinitis: Implications for management.
Clin Exp Allergy. 49:6–16. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang Y, Lan F and Zhang L: Advances and
highlights in allergic rhinitis. Allergy. 76:3383–3389.
2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Beken B, Eguiluz-Gracia I, Yazıcıoğlu M
and Campo P: Local allergic rhinitis: A pediatric perspective. Turk
J Pediatr. 62:701–710. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang L, Lv Q, Song X, Jiang K and Zhang J:
ADRB2 suppresses IL-13-induced allergic rhinitis inflammatory
cytokine regulated by miR-15a-5p. Hum Cell. 32:306–315.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Teng Y, Zhang R, Liu C, Zhou L, Wang H,
Zhuang W, Huang Y and Hong Z: miR-143 inhibits
interleukin-13-induced inflammatory cytokine and mucus production
in nasal epithelial cells from allergic rhinitis patients by
targeting IL13Rα1. Biochem Biophys Res Commun. 457:58–64.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Novelli M, Menegazzi M, Beffy P, Porozov
S, Gregorelli A, Giacopelli D, De Tata V and Masiello P: St. John's
wort extract and hyperforin inhibit multiple phosphorylation steps
of cytokine signaling and prevent inflammatory and apoptotic gene
induction in pancreatic β cells. Int J Biochem Cell Biol.
81:92–104. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pavón-Romero GF, Parra-Vargas MI,
Ramírez-Jiménez F, Melgoza-Ruiz E, Serrano-Pérez NH and Teran LM:
Allergen immunotherapy: Current and future trends. Cells.
11(212)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Meinke MC, Schanzer S, Haag SF, Casetti F,
Müller ML, Wölfle U, Kleemann A, Lademann J and Schempp CM: In vivo
photoprotective and anti-inflammatory effect of hyperforin is
associated with high antioxidant activity in vitro and ex vivo. Eur
J Pharm Biopharm. 81:346–350. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Takada H, Yonekawa J, Matsumoto M, Furuya
K and Sokabe M: Hyperforin/HP-β-cyclodextrin enhances
mechanosensitive Ca2+ signaling in HaCaT keratinocytes
and in atopic skin ex vivo which accelerates wound healing. Biomed
Res Int. 2017(8701801)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Brondz I: Super antibiotics, part II.
Hyperforin, mass spectroscopy (MS) and gas chromatography-mass
spectrometry (GC-MS), evidence of permeability of the blood-testis
barrier (BTB) and the blood-brain barrier (BBB) to hyperforin. Int
J Anal Mass Spectrom Chromatogr. 4:66–73. 2016.
|
|
28
|
Marrelli M, Statti G, Conforti F and
Menichini F: New potential pharmaceutical applications of hypericum
species. Mini Rev Med Chem. 16:710–720. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen D, Xiong XQ, Zang YH, Tong Y, Zhou B,
Chen Q, Li YH, Gao XY, Kang YM and Zhu GQ: BCL6 attenuates renal
inflammation via negative regulation of NLRP3 transcription. Cell
Death Dis. 8(e3156)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Béguelin W, Teater M, Gearhart MD, Calvo
Fernández MT, Goldstein RL, Cárdenas MG, Hatzi K, Rosen M, Shen H,
Corcoran CM, et al: EZH2 and BCL6 cooperate to assemble CBX8-BCOR
complex to repress bivalent promoters, mediate germinal center
formation and lymphomagenesis. Cancer Cell. 30:197–213.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Peng Y, Li XQ and Qiu QH: Detection of
differentially expressed gene of allergic rhinitis based on RT²
profiler PCR array. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za
Zhi. 31:869–872. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
32
|
Gu Y, Luo M, Li Y, Su Z, Wang Y, Chen X,
Zhang S, Sun W and Kong X: Bcl6 knockdown aggravates hypoxia injury
in cardiomyocytes via the P38 pathway. Cell Biol Int. 43:108–116.
2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Long S and Zhang H: MIR-181A-5P attenuates
ovalbumin-induced allergic inflammation in nasal epithelial cells
by targeting IL-33/P38 MAPK pathway. Clin Invest Med. 44:E31–E38.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Roh KB, Jung E, Park D and Lee J: Fumaric
acid attenuates the eotaxin-1 expression in TNF-α-stimulated
fibroblasts by suppressing p38 MAPK-dependent NF-κB signaling. Food
Chem Toxicol. 58:423–431. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Park JY, Choi JH, Lee SN, Cho HJ, Ahn JS,
Kim YB, Park DY, Park SC, Kim SI, Kang MJ, et al: Protein arginine
methyltransferase 1 contributes to the development of allergic
rhinitis by promoting the production of epithelial-derived
cytokines. J Allergy Clin Immunol. 147:1720–1731. 2021.PubMed/NCBI View Article : Google Scholar
|
